Stada Group
Sebastian Thelen has extensive work experience in supply chain management. Sebastian started their career at BASF in 2001, where they held various roles in supply chain management and import/export operations in both Germany and the USA. Sebastian worked at BASF until 2023, serving as the Director of Supply Chain Management Personal Care Europe. In 2023, they joined the STADA Group as the Director of Global Supply Chain Excellence.
Sebastian Thelen attended DHBW Mannheim from 2001 to 2004, where they obtained a Diplom (BA) degree in Wirtschaftsinformatik. Sebastian also received a certification from APICS for CPIM in 2012.
This person is not in any offices
Stada Group
14 followers
Stada Arzneimittel AG is a Germany-based holding company active in the pharmaceutical sector and healthcare market. The Company develops and markets products with off-patent active pharmaceutical ingredients. The Company’s primary business segments are Generics and Branded Products. The Generics segment comprises low-priced and active-ingredient products. The Branded Products segment focuses on multisource products accessible without active ingredient research, notably anti-enzymatic food intolerance drugs that are marketed by the subsidiary SCIOTEC Diagnostics Technologies. The Company's generic drugs are marketed by the Group subsidiary, STADApharm GmbH. Non-core activities of the Company encompass Commercial Business segment, which includes activities with primarily trading character such as wholesaling activities. The Company operates STADA Pharmaceuticals Australia Pty Ltd and STADA IT SOLUTIONS DOO as subsidiaries.